Benjamin Spieler
Radiation Oncology · Miami, FLNPI 1447614441
Payments from drug & device makers
What this record shows
This record is dominated by travel and lodging: $1,030 of the $1,352 with a category attached, or 76.2%. Reflexion Medical, Inc. accounts for 89.1% of it on its own, with 2 other manufacturers making up the rest.
Across 5 payments — averaging $270.40 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Reflexion Medical, Inc.$1K
- Regeneron Healthcare Solutions, Inc.$128
- Boston Scientific$18
Across 1 payment — averaging $91,500 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Siemens Medical Solutions USA, Inc.$92K
What the payments were for
- Travel & lodging$1,03076%
- Food & beverage$32224%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Reflexion Medical, Inc. | 3 | $1,205 |
| Regeneron Healthcare Solutions, Inc. | 1 | $128 |
| Boston Scientific | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$1,352 in reported general payments places this provider in the 65th percentile of 465 radiation oncology providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MyrbetriqMirabegron | 12 | $10,080 |
| Tamsulosin Hcl | 12 | $81 |
| Clonazepam | 15 | $66 |
Paid to pharmacies, not to this prescriber.
Other radiation oncology in Miami
- Marcio FagundesMiami$274K
- Rupesh KotechaMiami$208K
- Michael ChuongMiami$152K
- Marcus BredelMiami$64K
- Minesh MehtaMiami$38K
- Brandon MahalMiami$28K
- Matthew AbramowitzMiami$23K
- Ana BoteroMiami$21K
- Alan Dal PraMiami$10K
- Ahmed AklMiami$8K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.